Interventional Cardiology

LVAD patient Autumn Bowling with her cardiologist, Sandip Zalawadiya, MBBS, during a follow-up visit.

LVAD, medication therapy help patient’s heart recover full function

Six months receiving an LVAD at Vanderbilt, Autumn Bowling’s heart fully recovered its function and doctors were able to turn the device off, a rare feat.

New Physician Spotlight: Colin Barker

Colin Barker, MD, a national leader in percutaneous heart valve therapies, has joined Vanderbilt University Medical Center as the new director of Interventional Cardiology. He began seeing patients July 2.

Image of pain pills (iStock Photo)

Study tracks medication-related problems after hospital discharge

As more and better treatments are developed for heart disease, it is becoming more difficult to safely manage care as patients return home from the hospital. A new study led by Vanderbilt researchers highlights growing concern that the period after hospital discharge is a risky time, especially for cardiac patients.

Heart illustration

Vanderbilt Heart to participate in CoreValve clinical trial

Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart’s aortic valve.